Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 6, 2005, Pages 463-474

  Monjazeb, Arta M ^a   High, Kevin P ^a   Koumenis, Constantinos ^a   Chilton, Floyd H ^a,b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b Pilot Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ARACHIDONIC ACID; ETOPOSIDE; LIGASE INHIBITOR; LONG CHAIN FATTY ACID COENZYME A LIGASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLT 98625; PROSTAGLANDIN SYNTHASE INHIBITOR; TRIACSIN C; UNCLASSIFIED DRUG;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

ACYLTRANSFERASES; APOPTOSIS; ARACHIDONIC ACID; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; COENZYME A LIGASES; DRUG SYNERGISM; HELA CELLS; HUMANS; IMIDAZOLES; NITROBENZENES; ORGANOPHOSPHORUS COMPOUNDS; SULFONAMIDES; TRIAZENES;

EID: 27644468395     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.07.009     Document Type: Article

References (41)

1. P. Greenwald Cancer prevention clinical trials J. Clin. Oncol. 20 2002 14S 22S
2. S.H. Bae, E.S. Jung, Y.M. Park, B.S. Kim, B.K. Kim, D.G. Kim, and W.S. Ryu Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398 Clin. Cancer Res. 7 2001 1410 1418
3. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
4. A. Kokawa, H. Kondo, T. Gotoda, H. Ono, D. Saito, S. Nakadaira, T. Kosuge, and S. Yoshida Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors Cancer 91 2001 333 338
5. S. Kulkarni, J.S. Rader, F. Zhang, H. Liapis, A.T. Koki, J.L. Masferrer, K. Subbaramaiah, and A.J. Dannenberg Cyclooxygenase-2 is overexpressed in human cervical cancer Clin.Cancer Res. 7 2001 429 434
6. R.A. Soslow, A.J. Dannenberg, D. Rush, B.M. Woerner, K.N. Khan, J. Masferrer, and A.T. Koki COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 2000 2637 2645
7. D. Bishop-Bailey, S. Calatayud, T.D. Warner, T. Hla, and J.A. Mitchell Prostaglandins and the regulation of tumor growth J. Environ. Pathol. Toxicol. Oncol. 21 2002 93 101
8. Y. Cao, and S.M. Prescott Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J. Cell Physiol. 190 2002 279 286
9. W. Dempke, C. Rie, A. Grothey, and H.J. Schmoll Cyclooxygenase-2: a novel target for cancer chemotherapy J. Cancer Res. Clin. Oncol. 127 2001 411 417
10. F. Marks, K. Muller-Decker, and G. Furstenberger A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism Toxicology 153 2000 11 26
11. T.W. Moody, J. Leyton, H. Zakowicz, T. Hida, Y. Kang, S. Jakowlew, L. You, L. Ozbun, H. Zia, J. Youngberg, and A. Malkinson Indomethacin reduces lung adenoma number in A/J mice Anticancer Res. 21 2001 1749 1755
12. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, E. Kwong, J.M. Trzaskos, J.F. Evans, and M.M. Taketo Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
13. J.G. Rozic, C. Chakraborty, and P.K. Lala Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration invasiveness and angiogenesis, Int. J. Cancer 93 2001 497 506
14. M.J. Thun, M.M. Namboodiri, and C.W. Heath Jr. Aspirin use and reduced risk of fatal colon cancer N. Engl. J. Med. 325 1991 1593 1596
15. S.A. Khuder, and A.B. Mutgi Breast cancer and NSAID use: a meta-analysis Br. J. Cancer 84 2001 1188 1192
16. D.M. Schreinemachers, and R.B. Everson Aspirin use and lung colon, and breast cancer incidence in a prospective study, Epidemiology 5 1994 138 146
17. M.J. Thun, M.M. Namboodiri, E.E. Calle, W.D. Flanders, and C.W. Heath Jr. Aspirin use and risk of fatal cancer Cancer Res. 53 1993 1322 1327
18. M.B. Hansen-Petrik, M.F. McEntee, B. Jull, H. Shi, M.B. Zemel, and J. Whelan Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice Cancer Res. 62 2002 403 408
19. H. Sheng, J. Shao, J.D. Morrow, R.D. Beauchamp, and R.N. DuBois Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 58 1998 362 366
20. K. Sumitani, R. Kamijo, T. Toyoshima, Y. Nakanishi, K. Takizawa, M. Hatori, and M. Nagumo Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production J. Oral Pathol. Med. 30 2001 41 47
21. G.A. Piazza, A.L. Rahm, M. Krutzsch, G. Sperl, N.S. Paranka, P.H. Gross, K. Brendel, R.W. Burt, D.S. Alberts, and R. Pamukcu Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis Cancer Res. 55 1995 3110 3116
22. X. Zhang, S.G. Morham, R. Langenbach, and D.A. Young Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts J.Exp.Med. 190 1999 451 459
23. Y. Cao, A.T. Pearman, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott Intracellular unesterified arachidonic acid signals apoptosis Proc. Natl. Acad. Sci. USA 97 2000 11280 11285
24. T.A. Chan, P.J. Morin, B. Vogelstein, and K.W. Kinzler Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis Proc. Natl. Acad. Sci. USA 95 1998 681 686
25. A.M. Monjazeb, C.E. Clay, K.P. High, and F.H. Chilton Antineoplastic properties of arachidonic acid and its metabolites Prostaglandins Leukot. Essent. Fatty Acids 66 2002 5 12
26. A.J. Trimboli, B.M. Waite, G. Atsumi, A.N. Fonteh, A.M. Namen, C.E. Clay, T.E. Kute, K.P. High, M.C. Willingham, and F.H. Chilton Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells Cancer Res. 59 1999 6171 6177
27. S. Jayadev, C.M. Linardic, and Y.A. Hannun Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha J. Biol. Chem. 269 1994 5757 5763
28. M. Koller, P. Wachtler, A. David, G. Muhr, and W. Konig Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes Inflammation 21 1997 463 474
29. I. Shureiqi, and S.M. Lippman Lipoxygenase modulation to reverse carcinogenesis Cancer Res. 61 2001 6307 6312
30. F.H. Chilton, A.N. Fonteh, M.E. Surette, M. Triggiani, and J.D. Winkler Control of arachidonate levels within inflammatory cells Biochim. Biophys. Acta. 1299 1996 1 15
31. Y. Cao, K.B. Dave, T.P. Doan, and S.M. Prescott Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma Cancer Res. 61 2001 8429 8434
32. J.D. Winkler, T. Eris, C.M. Sung, M. Chabot-Fletcher, R.J. Mayer, M.E. Surette, and F.H. Chilton Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cells J. Pharmacol. Exp. Ther. 279 1996 956 966
33. F.H. Chilton, A.N. Fonteh, C.M. Hung, D.M. Hickey, T.J. Torphy, R.J. Mayer, L.A. Marshall, J.D. Heravi, and J.D. Winkler Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils Biochemistry 34 1995 5403 5410
34. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Med. Sci. 37 1959 911 917
35. M.E. Surette, A.N. Fonteh, C. Bernatchez, and F.H. Chilton Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells Carcinogenesis 20 1999 757 763
36. J.B. Barham, M.B. Edens, A.N. Fonteh, M.M. Johnson, L. Easter, and F.H. Chilton Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans J. Nutr. 130 2000 1925 1931
37. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
38. J.H. Capdevila, and J.R. Falck The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation Biochem. Biophys. Res. Commun. 285 2001 571 576
39. Q. Chen, M. Galleano, and A.I. Cederbaum Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P-4502E1 Alcohol Clin. Exp. Res. 22 1998 782 784
40. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
41. C.E. Clay, A.M. Namen, G. Atsumi, A.J. Trimboli, A.N. Fonteh, K.P. High, and F.H. Chilton Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells J. Investig. Med. 49 2001 413 420